English

BIOCEPT INC

EDGAR

BIOC Quarterly report (10-Q) · filed 2023-08-14

122 filing records in this dataset, filed from 2013-09-23 to 2023-08-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

600 thousand USD

2023 Q2 · USD

Exact inputs and evidence

Revenue: 600000 USD Source

Operating margin

-1,019%

2023 Q2 · %

Exact inputs and evidence

Operating Income: -6114000 USD Source
Revenue: 600000 USD Source

Operating cash flow

-3.09 million USD

2023 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -9280000 USD Source
Operating Cash Flow: -6194000 USD Source

Free cash flow

-3.18 million USD

2023 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -9280000 USD Source
Operating Cash Flow: -6194000 USD Source
Capital Expenditure: 188000 USD Source
Capital Expenditure: 91000 USD Source

Cash and cash equivalents: 679 thousand USD 2016-09-30 Source
Exact value

678855 USD
Long-term debt including current maturities: Not available
Shares outstanding: 2.41 million shares 2023-06-30 Source
Exact value

2407381 shares

Reported share-count change

-85.77% · -14.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

16922868 shares · 2022-06-30· Source
2407381 shares · 2023-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.39 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Revenue: 1000000 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 25858000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 26771000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 700000 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 600000 USD · 2023-04-01 – 2023-06-30 Source

Net income

-30.6 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Net income: -10125000 USD · 2022-07-01 – 2022-09-30 Source
Net income: -32100000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -22400000 USD · 2022-01-01 – 2022-09-30 Source
Net income: -7144000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -3631000 USD · 2023-04-01 – 2023-06-30 Source

Operating cash flow

-17.6 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Operating cash flow: -9047000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -4972000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -13289000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -9047000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -6194000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -9280000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -6194000 USD · 2023-01-01 – 2023-03-31 Source

Capital expenditure

680 thousand USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Capital expenditure: 671000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 315000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 807000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 671000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 91000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 188000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 91000 USD · 2023-01-01 – 2023-03-31 Source

Free cash flow

-18.3 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Operating cash flow: -9047000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -4972000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -13289000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -9047000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -6194000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -9280000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -6194000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 671000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 315000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 807000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 671000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 91000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 188000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 91000 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-08-14.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2022-12-31
Operating income: 10 of 11 periods available· newest 2022-12-31
Net income: 10 of 11 periods available· newest 2022-12-31
Operating cash flow: 10 of 11 periods available· newest 2022-12-31
Capital expenditure: 10 of 11 periods available· newest 2022-12-31
Total assets: 10 of 11 periods available· newest 2022-12-31
Total liabilities: 10 of 11 periods available· newest 2022-12-31
Current assets: 10 of 11 periods available· newest 2022-12-31
Current liabilities: 10 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2015-12-31
long term debt: No compatible figures in this window
Shares outstanding: 10 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-57.8%

Prior period

USD 61.25 million

2021-01-01 – 2021-12-31
Current period

USD 25.86 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

25858000 − 61249000 = -35391000 USD

61249000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
25858000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOCEPT INC · 2022-12-31 BIOCEPT INC (edgar:1044378) Year-over-year change in Revenue: -35391000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 25858000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#2071571 Filing: 000095017023013109 Input fundies:Revenue: 61249000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#2073752 Filing: 000095017023013109
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 29.3 million

Prior period

−USD 2.8 million

2021-01-01 – 2021-12-31
Current period

−USD 32.1 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-32100000 − -2800000 = -29300000 USD

-2800000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-32100000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOCEPT INC · 2022-12-31 BIOCEPT INC (edgar:1044378) Year-over-year change in Net income: -29300000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -32100000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#2001298 Filing: 000095017023013109 Input fundies:NetIncome: -2800000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#2002012 Filing: 000095017023013109
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-460.1%

Prior period

USD 3.69 million

2021-01-01 – 2021-12-31
Current period

−USD 13.29 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-13289000 − 3690000 = -16979000 USD

3690000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-13289000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOCEPT INC · 2022-12-31 BIOCEPT INC (edgar:1044378) Year-over-year change in Operating cash flow: -16979000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13289000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1898918 Filing: 000095017023013109 Input fundies:OperatingCashFlow: 3690000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1900921 Filing: 000095017023013109
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-48.7%

Prior period

USD 1.57 million

2021-01-01 – 2021-12-31
Current period

USD 807,000

2022-01-01 – 2022-12-31

Exact inputs and evidence

807000 − 1572000 = -765000 USD

1572000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
807000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIOCEPT INC · 2022-12-31 BIOCEPT INC (edgar:1044378) Year-over-year change in Capital expenditure: -765000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 807000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1906711 Filing: 000095017023013109 Input fundies:CapitalExpenditure: 1572000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1909031 Filing: 000095017023013109
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 25.86 million 100% of revenue
Operating costs Derived USD 57.84 million 224% of revenue
Operating income −USD 31.98 million −124% of revenue
Tax, interest and other Derived USD 117,000 0.5% of revenue
Net income −USD 32.1 million −124% of revenue

Cash

Operating cash flow −USD 13.29 million −51% of revenue
Capital expenditure USD 807,000 3.1% of revenue
Free cash flow Derived −USD 14.1 million −55% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 Operating loss: operating costs were 6,018% of revenue.
2014 Operating loss: operating costs were 10,499% of revenue.
2015 Operating loss: operating costs were 2,791% of revenue.
2016 Operating loss: operating costs were 659% of revenue.
2017 Operating loss: operating costs were 518% of revenue.
2018 Operating loss: operating costs were 846% of revenue.
2019 Operating loss: operating costs were 517% of revenue.
2020 Operating loss: operating costs were 156% of revenue.
2021 Operating loss: operating costs were 104% of revenue.
2022 Operating loss: operating costs were 224% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2013-01-01 – 2013-12-31	134245	8078676 Derived	-7944431	1288752 Derived	-9233183	-6203074 Derived	Source 2013-01-01 – 2013-12-31: 134245 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -7944431 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -9233183 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -6202363 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 711 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	133415	14007339 Derived	-13873924	1992122 Derived	-15866046	-14970577 Derived	Source 2014-01-01 – 2014-12-31: 133415 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -13873924 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -15866046 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -14575652 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 394925 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	609909	17020712 Derived	-16410803	538723 Derived	-16949526	-15320001 Derived	Source 2015-01-01 – 2015-12-31: 609909 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -16410803 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -16949526 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -15154841 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 165160 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	3223096	21248133 Derived	-18025037	374285 Derived	-18399322	-16179123 Derived	Source 2016-01-01 – 2016-12-31: 3223096 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -18025037 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -18399322 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -15697058 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 482065 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	5068663	26243369 Derived	-21174706	439031 Derived	-21613737	-21050906 Derived	Source 2017-01-01 – 2017-12-31: 5068663 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -21174706 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -21613737 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -19650726 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 1400180 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	3250298	27509037 Derived	-24258739	312862 Derived	-24571601	-22500471 Derived	Source 2018-01-01 – 2018-12-31: 3250298 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -24258739 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -24571601 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -22355218 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 145253 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	5528566	28585505 Derived	-23056939	2081100 Derived	-25138039	-23784561 Derived	Source 2019-01-01 – 2019-12-31: 5528566 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -23056939 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -25138039 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -23049261 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 735300 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	27461000	42930000 Derived	-15469000	2331000 Derived	-17800000	-20667000 Derived	Source 2020-01-01 – 2020-12-31: 27461000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -15469000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -17800000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -19800000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 867000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	61249000	63658000 Derived	-2409000	391000 Derived	-2800000	2118000 Derived	Source 2021-01-01 – 2021-12-31: 61249000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -2409000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -2800000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 3690000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 1572000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	25858000	57841000 Derived	-31983000	117000 Derived	-32100000	-14096000 Derived	Source 2022-01-01 – 2022-12-31: 25858000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -31983000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -32100000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -13289000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 807000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 25.9M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Revenue	134245	Revenue: 134245 Open source
20142014-12-31	Revenue	133415	Revenue: 133415 Open source
20152015-12-31	Revenue	609909	Revenue: 609909 Open source
20162016-12-31	Revenue	3223096	Revenue: 3223096 Open source
20172017-12-31	Revenue	5068663	Revenue: 5068663 Open source
20182018-12-31	Revenue	3250298	Revenue: 3250298 Open source
20192019-12-31	Revenue	5528566	Revenue: 5528566 Open source
20202020-12-31	Revenue	27461000	Revenue: 27461000 Open source
20212021-12-31	Revenue	61249000	Revenue: 61249000 Open source
20222022-12-31	Revenue	25858000	Revenue: 25858000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-57.8% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Year over year	No prior comparable period	Revenue: 134245 Open source
20142014-12-31	Year over year	-0.6%	Revenue: 133415 Open source Revenue: 134245 Open source
20152015-12-31	Year over year	357.2%	Revenue: 609909 Open source Revenue: 133415 Open source
20162016-12-31	Year over year	428.5%	Revenue: 3223096 Open source Revenue: 609909 Open source
20172017-12-31	Year over year	57.3%	Revenue: 5068663 Open source Revenue: 3223096 Open source
20182018-12-31	Year over year	-35.9%	Revenue: 3250298 Open source Revenue: 5068663 Open source
20192019-12-31	Year over year	70.1%	Revenue: 5528566 Open source Revenue: 3250298 Open source
20202020-12-31	Year over year	396.7%	Revenue: 27461000 Open source Revenue: 5528566 Open source
20212021-12-31	Year over year	123%	Revenue: 61249000 Open source Revenue: 27461000 Open source
20222022-12-31	Year over year	-57.8%	Revenue: 25858000 Open source Revenue: 61249000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -123.7% 2022

Net margin -124.1% 2022

Free cash flow margin -54.5% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Operating margin	-5,917.9%	Operating Income: -7944431 Open source Revenue: 134245 Open source
20142014-12-31	Operating margin	-10,399.1%	Operating Income: -13873924 Open source Revenue: 133415 Open source
20152015-12-31	Operating margin	-2,690.7%	Operating Income: -16410803 Open source Revenue: 609909 Open source
20162016-12-31	Operating margin	-559.2%	Operating Income: -18025037 Open source Revenue: 3223096 Open source
20172017-12-31	Operating margin	-417.8%	Operating Income: -21174706 Open source Revenue: 5068663 Open source
20182018-12-31	Operating margin	-746.4%	Operating Income: -24258739 Open source Revenue: 3250298 Open source
20192019-12-31	Operating margin	-417.1%	Operating Income: -23056939 Open source Revenue: 5528566 Open source
20202020-12-31	Operating margin	-56.3%	Operating Income: -15469000 Open source Revenue: 27461000 Open source
20212021-12-31	Operating margin	-3.9%	Operating Income: -2409000 Open source Revenue: 61249000 Open source
20222022-12-31	Operating margin	-123.7%	Operating Income: -31983000 Open source Revenue: 25858000 Open source
20132013-12-31	Net margin	-6,877.9%	Net Income: -9233183 Open source Revenue: 134245 Open source
20142014-12-31	Net margin	-11,892.3%	Net Income: -15866046 Open source Revenue: 133415 Open source
20152015-12-31	Net margin	-2,779%	Net Income: -16949526 Open source Revenue: 609909 Open source
20162016-12-31	Net margin	-570.9%	Net Income: -18399322 Open source Revenue: 3223096 Open source
20172017-12-31	Net margin	-426.4%	Net Income: -21613737 Open source Revenue: 5068663 Open source
20182018-12-31	Net margin	-756%	Net Income: -24571601 Open source Revenue: 3250298 Open source
20192019-12-31	Net margin	-454.7%	Net Income: -25138039 Open source Revenue: 5528566 Open source
20202020-12-31	Net margin	-64.8%	Net Income: -17800000 Open source Revenue: 27461000 Open source
20212021-12-31	Net margin	-4.6%	Net Income: -2800000 Open source Revenue: 61249000 Open source
20222022-12-31	Net margin	-124.1%	Net Income: -32100000 Open source Revenue: 25858000 Open source
20132013-12-31	Free cash flow margin	-4,620.7%	Revenue: 134245 Open source Operating Cash Flow: -6202363 Open source Capital Expenditure: 711 Open source
20142014-12-31	Free cash flow margin	-11,221.1%	Revenue: 133415 Open source Operating Cash Flow: -14575652 Open source Capital Expenditure: 394925 Open source
20152015-12-31	Free cash flow margin	-2,511.9%	Revenue: 609909 Open source Operating Cash Flow: -15154841 Open source Capital Expenditure: 165160 Open source
20162016-12-31	Free cash flow margin	-502%	Revenue: 3223096 Open source Operating Cash Flow: -15697058 Open source Capital Expenditure: 482065 Open source
20172017-12-31	Free cash flow margin	-415.3%	Revenue: 5068663 Open source Operating Cash Flow: -19650726 Open source Capital Expenditure: 1400180 Open source
20182018-12-31	Free cash flow margin	-692.3%	Revenue: 3250298 Open source Operating Cash Flow: -22355218 Open source Capital Expenditure: 145253 Open source
20192019-12-31	Free cash flow margin	-430.2%	Revenue: 5528566 Open source Operating Cash Flow: -23049261 Open source Capital Expenditure: 735300 Open source
20202020-12-31	Free cash flow margin	-75.3%	Revenue: 27461000 Open source Operating Cash Flow: -19800000 Open source Capital Expenditure: 867000 Open source
20212021-12-31	Free cash flow margin	3.5%	Revenue: 61249000 Open source Operating Cash Flow: 3690000 Open source Capital Expenditure: 1572000 Open source
20222022-12-31	Free cash flow margin	-54.5%	Revenue: 25858000 Open source Operating Cash Flow: -13289000 Open source Capital Expenditure: 807000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.3M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Operating cash flow	-6202363	Operating Cash Flow: -6202363 Open source
20142014-12-31	Operating cash flow	-14575652	Operating Cash Flow: -14575652 Open source
20152015-12-31	Operating cash flow	-15154841	Operating Cash Flow: -15154841 Open source
20162016-12-31	Operating cash flow	-15697058	Operating Cash Flow: -15697058 Open source
20172017-12-31	Operating cash flow	-19650726	Operating Cash Flow: -19650726 Open source
20182018-12-31	Operating cash flow	-22355218	Operating Cash Flow: -22355218 Open source
20192019-12-31	Operating cash flow	-23049261	Operating Cash Flow: -23049261 Open source
20202020-12-31	Operating cash flow	-19800000	Operating Cash Flow: -19800000 Open source
20212021-12-31	Operating cash flow	3690000	Operating Cash Flow: 3690000 Open source
20222022-12-31	Operating cash flow	-13289000	Operating Cash Flow: -13289000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.1M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Free cash flow	-6203074	Operating Cash Flow: -6202363 Open source Capital Expenditure: 711 Open source
20142014-12-31	Free cash flow	-14970577	Operating Cash Flow: -14575652 Open source Capital Expenditure: 394925 Open source
20152015-12-31	Free cash flow	-15320001	Operating Cash Flow: -15154841 Open source Capital Expenditure: 165160 Open source
20162016-12-31	Free cash flow	-16179123	Operating Cash Flow: -15697058 Open source Capital Expenditure: 482065 Open source
20172017-12-31	Free cash flow	-21050906	Operating Cash Flow: -19650726 Open source Capital Expenditure: 1400180 Open source
20182018-12-31	Free cash flow	-22500471	Operating Cash Flow: -22355218 Open source Capital Expenditure: 145253 Open source
20192019-12-31	Free cash flow	-23784561	Operating Cash Flow: -23049261 Open source Capital Expenditure: 735300 Open source
20202020-12-31	Free cash flow	-20667000	Operating Cash Flow: -19800000 Open source Capital Expenditure: 867000 Open source
20212021-12-31	Free cash flow	2118000	Operating Cash Flow: 3690000 Open source Capital Expenditure: 1572000 Open source
20222022-12-31	Free cash flow	-14096000	Operating Cash Flow: -13289000 Open source Capital Expenditure: 807000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

71.3% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Liabilities / assets	1,036.7%	Total Liabilities: 13785733 Open source Total Assets: 1329719 Open source
20142014-12-31	Liabilities / assets	103.4%	Total Liabilities: 6785622 Open source Total Assets: 6565053 Open source
20152015-12-31	Liabilities / assets	65.1%	Total Liabilities: 6894183 Open source Total Assets: 10586918 Open source
20162016-12-31	Liabilities / assets	91.3%	Total Liabilities: 6919665 Open source Total Assets: 7578326 Open source
20172017-12-31	Liabilities / assets	82.4%	Total Liabilities: 6082872 Open source Total Assets: 7378906 Open source
20182018-12-31	Liabilities / assets	65.2%	Total Liabilities: 5707784 Open source Total Assets: 8750303 Open source
20192019-12-31	Liabilities / assets	36.8%	Total Liabilities: 6532001 Open source Total Assets: 17732644 Open source
20202020-12-31	Liabilities / assets	50.1%	Total Liabilities: 23761000 Open source Total Assets: 47453000 Open source
20212021-12-31	Liabilities / assets	38%	Total Liabilities: 22937000 Open source Total Assets: 60417000 Open source
20222022-12-31	Liabilities / assets	71.3%	Total Liabilities: 22013000 Open source Total Assets: 30873000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.97× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Current assets / current liabilities	0.07×	Current Assets: 970332 Open source Current Liabilities: 13323732 Open source
20142014-12-31	Current assets / current liabilities	4.13×	Current Assets: 5902631 Open source Current Liabilities: 1430783 Open source
20152015-12-31	Current assets / current liabilities	2.89×	Current Assets: 9640738 Open source Current Liabilities: 3340788 Open source
20162016-12-31	Current assets / current liabilities	1.31×	Current Assets: 5771995 Open source Current Liabilities: 4393552 Open source
20172017-12-31	Current assets / current liabilities	0.91×	Current Assets: 4255339 Open source Current Liabilities: 4661345 Open source
20182018-12-31	Current assets / current liabilities	1.3×	Current Assets: 6010881 Open source Current Liabilities: 4609647 Open source
20192019-12-31	Current assets / current liabilities	2.5×	Current Assets: 13892597 Open source Current Liabilities: 5558812 Open source
20202020-12-31	Current assets / current liabilities	2.61×	Current Assets: 32595000 Open source Current Liabilities: 12496000 Open source
20212021-12-31	Current assets / current liabilities	3.88×	Current Assets: 45692000 Open source Current Liabilities: 11773000 Open source
20222022-12-31	Current assets / current liabilities	2.97×	Current Assets: 16343000 Open source Current Liabilities: 5506000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	−USD 9.23 million Exact value Exact value: -9233183 USD 2013-01-01 – 2013-12-31: -9233183 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2013-12-31 BIOCEPT INC (edgar:1044378) Net Income: -9233183 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9233183 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459015001482/bioc-20141231.xml#272789 Filing: 000156459015001482 The citation records this snapshot. The page link may show a newer release later.	−USD 6.2 million Exact value Exact value: -6202363 USD 2013-01-01 – 2013-12-31: -6202363 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2013-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: -6202363 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6202363 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459015001482/bioc-20141231.xml#294455 Filing: 000156459015001482 The citation records this snapshot. The page link may show a newer release later.	USD 711 Exact value Exact value: 711 USD 2013-01-01 – 2013-12-31: 711 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2013-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 711 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 711 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459015001482/bioc-20141231.xml#294956 Filing: 000156459015001482 The citation records this snapshot. The page link may show a newer release later.	−USD 6.2 million Calculation and evidence -6202363 − 711 USD Exact free cash flow: -6203074 USD 2013-01-01 – 2013-12-31: -6202363 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 711 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2013-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: -6203074 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6202363 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459015001482/bioc-20141231.xml#294455 Filing: 000156459015001482 Input fundies:CapitalExpenditure: 711 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459015001482/bioc-20141231.xml#294956 Filing: 000156459015001482 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 15.87 million Exact value Exact value: -15866046 USD 2014-01-01 – 2014-12-31: -15866046 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2014-12-31 BIOCEPT INC (edgar:1044378) Net Income: -15866046 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15866046 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459016014436/bioc-20151231.xml#265210 Filing: 000156459016014436 The citation records this snapshot. The page link may show a newer release later.	−USD 14.58 million Exact value Exact value: -14575652 USD 2014-01-01 – 2014-12-31: -14575652 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2014-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: -14575652 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14575652 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459016014436/bioc-20151231.xml#285991 Filing: 000156459016014436 The citation records this snapshot. The page link may show a newer release later.	USD 394,925 Exact value Exact value: 394925 USD 2014-01-01 – 2014-12-31: 394925 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2014-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 394925 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 394925 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459016014436/bioc-20151231.xml#286493 Filing: 000156459016014436 The citation records this snapshot. The page link may show a newer release later.	−USD 14.97 million Calculation and evidence -14575652 − 394925 USD Exact free cash flow: -14970577 USD 2014-01-01 – 2014-12-31: -14575652 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 394925 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2014-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: -14970577 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14575652 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459016014436/bioc-20151231.xml#285991 Filing: 000156459016014436 Input fundies:CapitalExpenditure: 394925 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459016014436/bioc-20151231.xml#286493 Filing: 000156459016014436 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 16.95 million Exact value Exact value: -16949526 USD 2015-01-01 – 2015-12-31: -16949526 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2015-12-31 BIOCEPT INC (edgar:1044378) Net Income: -16949526 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16949526 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459017005382/bioc-20161231.xml#174022 Filing: 000156459017005382 The citation records this snapshot. The page link may show a newer release later.	−USD 15.15 million Exact value Exact value: -15154841 USD 2015-01-01 – 2015-12-31: -15154841 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2015-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: -15154841 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15154841 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459017005382/bioc-20161231.xml#194496 Filing: 000156459017005382 The citation records this snapshot. The page link may show a newer release later.	USD 165,160 Exact value Exact value: 165160 USD 2015-01-01 – 2015-12-31: 165160 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2015-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 165160 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 165160 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459017005382/bioc-20161231.xml#195207 Filing: 000156459017005382 The citation records this snapshot. The page link may show a newer release later.	−USD 15.32 million Calculation and evidence -15154841 − 165160 USD Exact free cash flow: -15320001 USD 2015-01-01 – 2015-12-31: -15154841 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 165160 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2015-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: -15320001 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15154841 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459017005382/bioc-20161231.xml#194496 Filing: 000156459017005382 Input fundies:CapitalExpenditure: 165160 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459017005382/bioc-20161231.xml#195207 Filing: 000156459017005382 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 18.4 million Exact value Exact value: -18399322 USD 2016-01-01 – 2016-12-31: -18399322 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2016-12-31 BIOCEPT INC (edgar:1044378) Net Income: -18399322 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18399322 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459018006985/bioc-20171231.xml#197439 Filing: 000156459018006985 The citation records this snapshot. The page link may show a newer release later.	−USD 15.7 million Exact value Exact value: -15697058 USD 2016-01-01 – 2016-12-31: -15697058 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2016-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: -15697058 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15697058 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459018006985/bioc-20171231.xml#219515 Filing: 000156459018006985 The citation records this snapshot. The page link may show a newer release later.	USD 482,065 Exact value Exact value: 482065 USD 2016-01-01 – 2016-12-31: 482065 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2016-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 482065 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 482065 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459018006985/bioc-20171231.xml#220226 Filing: 000156459018006985 The citation records this snapshot. The page link may show a newer release later.	−USD 16.18 million Calculation and evidence -15697058 − 482065 USD Exact free cash flow: -16179123 USD 2016-01-01 – 2016-12-31: -15697058 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 482065 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2016-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: -16179123 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15697058 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459018006985/bioc-20171231.xml#219515 Filing: 000156459018006985 Input fundies:CapitalExpenditure: 482065 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459018006985/bioc-20171231.xml#220226 Filing: 000156459018006985 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 21.61 million Exact value Exact value: -21613737 USD 2017-01-01 – 2017-12-31: -21613737 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2017-12-31 BIOCEPT INC (edgar:1044378) Net Income: -21613737 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21613737 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459019009914/bioc-20181231.xml#206122 Filing: 000156459019009914 The citation records this snapshot. The page link may show a newer release later.	−USD 19.65 million Exact value Exact value: -19650726 USD 2017-01-01 – 2017-12-31: -19650726 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2017-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: -19650726 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19650726 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459019009914/bioc-20181231.xml#232462 Filing: 000156459019009914 The citation records this snapshot. The page link may show a newer release later.	USD 1.4 million Exact value Exact value: 1400180 USD 2017-01-01 – 2017-12-31: 1400180 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2017-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 1400180 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1400180 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459019009914/bioc-20181231.xml#232884 Filing: 000156459019009914 The citation records this snapshot. The page link may show a newer release later.	−USD 21.05 million Calculation and evidence -19650726 − 1400180 USD Exact free cash flow: -21050906 USD 2017-01-01 – 2017-12-31: -19650726 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1400180 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2017-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: -21050906 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19650726 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459019009914/bioc-20181231.xml#232462 Filing: 000156459019009914 Input fundies:CapitalExpenditure: 1400180 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459019009914/bioc-20181231.xml#232884 Filing: 000156459019009914 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 24.57 million Exact value Exact value: -24571601 USD 2018-01-01 – 2018-12-31: -24571601 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2018-12-31 BIOCEPT INC (edgar:1044378) Net Income: -24571601 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24571601 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459020013670/bioc-20191231.xml#250380 Filing: 000156459020013670 The citation records this snapshot. The page link may show a newer release later.	−USD 22.36 million Exact value Exact value: -22355218 USD 2018-01-01 – 2018-12-31: -22355218 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2018-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: -22355218 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22355218 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459020013670/bioc-20191231.xml#283518 Filing: 000156459020013670 The citation records this snapshot. The page link may show a newer release later.	USD 145,253 Exact value Exact value: 145253 USD 2018-01-01 – 2018-12-31: 145253 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2018-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 145253 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 145253 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459020013670/bioc-20191231.xml#283940 Filing: 000156459020013670 The citation records this snapshot. The page link may show a newer release later.	−USD 22.5 million Calculation and evidence -22355218 − 145253 USD Exact free cash flow: -22500471 USD 2018-01-01 – 2018-12-31: -22355218 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 145253 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2018-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: -22500471 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22355218 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459020013670/bioc-20191231.xml#283518 Filing: 000156459020013670 Input fundies:CapitalExpenditure: 145253 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459020013670/bioc-20191231.xml#283940 Filing: 000156459020013670 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 25.14 million Exact value Exact value: -25138039 USD 2019-01-01 – 2019-12-31: -25138039 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2019-12-31 BIOCEPT INC (edgar:1044378) Net Income: -25138039 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25138039 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459021017097/bioc-20201231.xml#237903 Filing: 000156459021017097 The citation records this snapshot. The page link may show a newer release later.	−USD 23.05 million Exact value Exact value: -23049261 USD 2019-01-01 – 2019-12-31: -23049261 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2019-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: -23049261 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23049261 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459021017097/bioc-20201231.xml#273711 Filing: 000156459021017097 The citation records this snapshot. The page link may show a newer release later.	USD 735,300 Exact value Exact value: 735300 USD 2019-01-01 – 2019-12-31: 735300 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2019-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 735300 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 735300 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459021017097/bioc-20201231.xml#274133 Filing: 000156459021017097 The citation records this snapshot. The page link may show a newer release later.	−USD 23.78 million Calculation and evidence -23049261 − 735300 USD Exact free cash flow: -23784561 USD 2019-01-01 – 2019-12-31: -23049261 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 735300 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2019-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: -23784561 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23049261 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459021017097/bioc-20201231.xml#273711 Filing: 000156459021017097 Input fundies:CapitalExpenditure: 735300 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459021017097/bioc-20201231.xml#274133 Filing: 000156459021017097 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 17.8 million Exact value Exact value: -17800000 USD 2020-01-01 – 2020-12-31: -17800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2020-12-31 BIOCEPT INC (edgar:1044378) Net Income: -17800000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17800000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459022013599/bioc-10k_20211231.htm#2056537 Filing: 000156459022013599 The citation records this snapshot. The page link may show a newer release later.	−USD 19.8 million Exact value Exact value: -19800000 USD 2020-01-01 – 2020-12-31: -19800000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2020-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: -19800000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19800000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459022013599/bioc-10k_20211231.htm#2057036 Filing: 000156459022013599 The citation records this snapshot. The page link may show a newer release later.	USD 867,000 Exact value Exact value: 867000 USD 2020-01-01 – 2020-12-31: 867000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2020-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 867000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 867000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459022013599/bioc-10k_20211231.htm#1975142 Filing: 000156459022013599 The citation records this snapshot. The page link may show a newer release later.	−USD 20.67 million Calculation and evidence -19800000 − 867000 USD Exact free cash flow: -20667000 USD 2020-01-01 – 2020-12-31: -19800000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 867000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2020-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: -20667000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19800000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459022013599/bioc-10k_20211231.htm#2057036 Filing: 000156459022013599 Input fundies:CapitalExpenditure: 867000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000156459022013599/bioc-10k_20211231.htm#1975142 Filing: 000156459022013599 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 2.8 million Exact value Exact value: -2800000 USD 2021-01-01 – 2021-12-31: -2800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2021-12-31 BIOCEPT INC (edgar:1044378) Net Income: -2800000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2800000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#2002012 Filing: 000095017023013109 The citation records this snapshot. The page link may show a newer release later.	USD 3.69 million Exact value Exact value: 3690000 USD 2021-01-01 – 2021-12-31: 3690000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2021-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: 3690000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3690000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1900921 Filing: 000095017023013109 The citation records this snapshot. The page link may show a newer release later.	USD 1.57 million Exact value Exact value: 1572000 USD 2021-01-01 – 2021-12-31: 1572000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2021-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 1572000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1572000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1909031 Filing: 000095017023013109 The citation records this snapshot. The page link may show a newer release later.	USD 2.12 million Calculation and evidence 3690000 − 1572000 USD Exact free cash flow: 2118000 USD 2021-01-01 – 2021-12-31: 3690000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1572000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2021-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: 2118000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3690000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1900921 Filing: 000095017023013109 Input fundies:CapitalExpenditure: 1572000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1909031 Filing: 000095017023013109 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 32.1 million Exact value Exact value: -32100000 USD 2022-01-01 – 2022-12-31: -32100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOCEPT INC · 2022-12-31 BIOCEPT INC (edgar:1044378) Net Income: -32100000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32100000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#2001298 Filing: 000095017023013109 The citation records this snapshot. The page link may show a newer release later.	−USD 13.29 million Exact value Exact value: -13289000 USD 2022-01-01 – 2022-12-31: -13289000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOCEPT INC · 2022-12-31 BIOCEPT INC (edgar:1044378) Operating Cash Flow: -13289000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13289000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1898918 Filing: 000095017023013109 The citation records this snapshot. The page link may show a newer release later.	USD 807,000 Exact value Exact value: 807000 USD 2022-01-01 – 2022-12-31: 807000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOCEPT INC · 2022-12-31 BIOCEPT INC (edgar:1044378) Capital Expenditure: 807000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 807000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1906711 Filing: 000095017023013109 The citation records this snapshot. The page link may show a newer release later.	−USD 14.1 million Calculation and evidence -13289000 − 807000 USD Exact free cash flow: -14096000 USD 2022-01-01 – 2022-12-31: -13289000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 807000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOCEPT INC · 2022-12-31 BIOCEPT INC (edgar:1044378) Free cash flow: -14096000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1044378?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13289000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1898918 Filing: 000095017023013109 Input fundies:CapitalExpenditure: 807000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1044378/000095017023013109/bioc-20221231.htm#1906711 Filing: 000095017023013109 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

122 filings · 3,013 latest values · 3,013 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001044378, 1044378, BIOC, edgar:1044378

Also known as BIOCEPT INC, Biocept, Inc.

BIOCEPT INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation